BackNextCell Pharma AB Overview

NextCell Pharma AB Total Current Liabilities

Track NextCell Pharma AB's total current liabilities ($11M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$11.34M

Peer trimmed avg / median

Loading

NextCell Pharma AB Total Current Liabilities History

Loading

NextCell Pharma AB vs. peers: Total Current Liabilities Comparison

Loading

NextCell Pharma AB Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NextCell Pharma AB (NXTCL.ST) FAQ

As of the most recent data (June 2026), NXTCL.ST shows a total current liabilities of $11M. Scroll down for historical charts and peer comparison views.

Tracking NXTCL.ST's total current liabilities over time shows whether NextCell Pharma AB is scaling, shrinking, or reshaping that part of the business. The current reading is $11M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has NextCell Pharma AB's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $11M) with ownership activity and broader fundamentals.

NextCell Pharma AB's total current liabilities is $11M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.